Pds biotech provides update on national cancer institute-led phase 2 clinical trial of pds0101-based combination

Temporary administrative suspension of recruitment – no safety or efficacy concerns related specifically to the novel pds0101-based combination study temporary administrative suspension of recruitment – no safety or efficacy concerns related specifically to the novel pds0101-based combination study
PDSB Ratings Summary
PDSB Quant Ranking